Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
67.71
+0.26 (+0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
13,504,067
Open
67.20
Bid (Size)
67.00 (7)
Ask (Size)
67.35 (8)
Prev. Close
67.45
Today's Range
66.92 - 68.19
52wk Range
64.41 - 83.25
Shares Outstanding
1,319,574,744
Dividend Yield
3.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Unpacking the Latest Options Trading Trends in CVS Health
Today 12:01 EDT
Via
Benzinga
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
Today 8:31 EDT
Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point.
Via
Investor's Business Daily
Performance
YTD
-16.25%
-16.25%
1 Month
-14.89%
-14.89%
3 Month
-8.31%
-8.31%
6 Month
-1.88%
-1.88%
1 Year
-8.36%
-8.36%
More News
Read More
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
April 29, 2024
Via
Investor's Business Daily
DoorDash: 5 Compelling Reasons to Buy the Dip
April 29, 2024
Via
MarketBeat
Topics
Death
Exposures
Death
3 Value Stocks to Buy on the Dip: April 2024
April 29, 2024
Via
InvestorPlace
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is This Beaten-Down Dividend Stock a Buy?
April 27, 2024
Via
The Motley Fool
Looking Into CVS Health's Recent Short Interest
April 23, 2024
Via
Benzinga
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
April 26, 2024
Via
Benzinga
5 High-Yielding Oversold Stocks with Bullish Ratings
April 26, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
7 blue chip stocks to Buy on the Dip: April 2024
April 25, 2024
Via
InvestorPlace
3 Absurdly Cheap Stocks to Buy and Hold for Years
April 25, 2024
Via
The Motley Fool
Put $5,000 in These 7 Blue-Chip Stocks Today
April 22, 2024
Via
InvestorPlace
Analyst Ratings For CVS Health
April 04, 2024
Via
Benzinga
Beat the Dow Jones With This Cash-Gushing Dividend Stock
April 21, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
The Smartest Dividend Stocks to Buy With $400 Right Now
April 20, 2024
Via
The Motley Fool
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
April 19, 2024
Via
Investor's Business Daily
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
April 17, 2024
Via
Benzinga
3 Defensive Stocks to Buy for Increased Volatility in April
April 17, 2024
Via
InvestorPlace
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
Via
InvestorPlace
Topics
ETFs
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
April 15, 2024
Via
Benzinga
Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now
April 12, 2024
Via
InvestorPlace
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Via
InvestorPlace
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
April 05, 2024
Via
Benzinga
Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review
April 05, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
